ADVANCED OR METASTATIC SOLID TUMOR
Clinical trials for ADVANCED OR METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new experimental drug called BGB-R046, given alone or with another drug (tislelizumab), in people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. The trial was terminat…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Experimental cancer drug THOR-707 tested in patients with advanced tumors
Disease control TerminatedThis study tested an experimental drug called THOR-707 in adults with advanced solid tumors that had spread. The goal was to find safe doses and see if the drug could shrink tumors when used alone or with other treatments. The study was stopped early, so results are limited.
Matched conditions: ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Synthorx, Inc, a Sanofi company • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Cancer drug trial halted early – what happened?
Disease control TerminatedThis phase 2 trial tested the drug futibatinib in 115 people with advanced solid tumors or blood cancers that have specific FGFR gene changes. The goal was to see if the drug could shrink tumors or cause remission. The study was terminated early, so final results are not yet clea…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Experimental cancer drug BGB-3245 studied in early trial
Disease control TerminatedThis early-phase study tested an experimental drug called BGB-3245 (brimarafenib) in 109 people with advanced solid tumors that had not responded to standard treatments. The drug is designed to block certain proteins that help cancer grow. The main goals were to check safety, fin…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: MapKure, LLC • Aim: Disease control
Last updated Jun 26, 2026 15:30 UTC